Melanotan-1 (10mg)

Melanotan 1, a synthetic analogue derived from alpha-melanocyte stimulating hormone, is clinically utilized in Europe to prevent sun-induced skin damage, particularly phototoxicity, in individuals affected by erythropoietic protoporphyria. Initially formulated as a sunless tanning solution, Melanotan 1 exhibits various physiological effects on blood pressure, feeding patterns, central nervous system functionality, and more. Currently, the peptide is undergoing phase 3 clinical trials for treating polymorphose light eruption and is in phase 2 trials for managing actinic keratosis—a specific sun-induced skin damage condition—and its severe variant, squamous cell carcinoma.